Suven Pharmaceuticals Limited (SUVENPHAR) - Cash Flow Conversion Efficiency

Latest as of December 2023: 0.013x

Based on the latest financial reports, Suven Pharmaceuticals Limited (SUVENPHAR) has a cash flow conversion efficiency ratio of 0.013x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs255.04 Million ≈ $2.76 Million USD) by net assets (Rs19.81 Billion ≈ $214.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SUVENPHAR market cap overview for the company's overall valuation and market capitalisation.

Suven Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Suven Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Suven Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore Suven Pharmaceuticals Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
KONINKLIJKE VOP.UNSP.ADR F:VPK	N/A
Premier Energies Limited NSE:PREMIERENE	0.144x
Choice Hotels International Inc NYSE:CHH	0.637x
Aurizon Holdings Ltd AU:AZJ	0.145x
Novanta Inc F:1GSN	0.011x
Hongda SHG:600331	-0.083x
Union Bank of Taiwan Pref TW:2838A	-0.155x
Acm Research Inc NASDAQ:ACMR	-0.014x

Annual Cash Flow Conversion Efficiency for Suven Pharmaceuticals Limited (2019–2025)

The table below shows the annual cash flow conversion efficiency of Suven Pharmaceuticals Limited from 2019 to 2025. View current stock price of Suven Pharmaceuticals Limited for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs18.41 Billion ≈ $199.06 Million	Rs2.88 Billion ≈ $31.16 Million	0.157x	-10.44%
2024-03-31	Rs20.51 Billion ≈ $221.77 Million	Rs3.58 Billion ≈ $38.77 Million	0.175x	-32.73%
2023-03-31	Rs17.35 Billion ≈ $187.65 Million	Rs4.51 Billion ≈ $48.76 Million	0.260x	+20.26%
2022-03-31	Rs15.27 Billion ≈ $165.16 Million	Rs3.30 Billion ≈ $35.69 Million	0.216x	-33.46%
2021-03-31	Rs11.81 Billion ≈ $127.70 Million	Rs3.83 Billion ≈ $41.47 Million	0.325x	-34.05%
2020-03-31	Rs8.45 Billion ≈ $91.36 Million	Rs4.16 Billion ≈ $44.98 Million	0.492x	+476.64%
2019-03-31	Rs5.90 Billion ≈ $63.84 Million	Rs504.05 Million ≈ $5.45 Million	0.085x	--

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3890 Global

#169 in India

Share Price

Rs1063.80

Change (1 day)

+0.00%

52-Week Range

Rs1063.80 - Rs1063.80

All Time High

Rs1334.20